 rational develop low-molecular-weight heparin clinic potenti prevent postop venou thrombosi low-molecular-weight heparin lmwh potenti antithrombot agent observ earli first lmwh fraction unfraction heparin ufh abil activ partial thromboplastin time aptt abil factor Xa second observ lmwh chemic depolar ufh antithrombot experiment anim model microvascular bleed experiment model equival antithrombot effect ufh lmwh platelet function impair vascular permeabl standard heparin lmwh biolog half-lif standard heparin number lmwh clinic trial gener orthoped surgeri treatment venou thrombosi lmwh effect orthoped surgeri effect standard heparin lmwh effect effect ufh postop thrombosi gener surgeri preliminari studi lmwh effect standard heparin treatment venou thrombosi studi relev outcom measur